Patients with major depressive disorder appear to have malfunctioning circadian rhythms, which could lead researchers to new avenues for treatment.
Advertisement
The Scientist
Most Recent
The commonly abused hallucinogen shows promise in extinguishing fear in rats, pointing to possible benefits for patients with post-traumatic stress disorder.
Depression in post-op breast cancer patients can cause tumors to establish in bone.
A newly recognized chemical factor in the brain, called neuritin, regulates plasticity and may play a role in depression.
Brain scans reveal the surprising secret of magic mushrooms’ hallucinogenic effect.
Researchers identify a gene that is more likely to be carried by people who are suicidal than depressed individuals who are not.
Firefighters who worked at the World Trade Center during the terrorist attacks of 9/11 and the event’s aftermath have higher rates of cancer.
A year and a half after soldiers have returned from war, impairments in the regulatory circuitry of the amygdala remain.
Particulates in the air can cause impaired learning and depression in mice.
The challenges of crystallizing membrane proteins—and how they’re being overcome
Page 1 of 1
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
